Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial

详细信息    查看全文

• 作者：Yasuo Hirayama ; Kunihiko Ishitani…
• 关键词：Duloxetine ; Neuropathy ; Chemotherapy ; Supportive care ; CIPN
• 刊名：International Journal of Clinical Oncology
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：20
• 期：5
• 页码：866-871
• 全文大小：456 KB
• 参考文献：1.Cavaletti G, Frigeni B, Lanzani F et al (2010) Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 46:479鈥?94CrossRef PubMed
  2.Cavaletti G, Cornblath DR, Merkies IS et al (2013) The Chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24:454鈥?62PubMed Central CrossRef PubMed
  3.Pachman DR, Barton DL, Watson JC et al (2011) Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther 90:377鈥?87CrossRef PubMed
  4.Rao RD, Michalak JC, Sloan JA et al (2007) Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110(9):2110鈥?118CrossRef PubMed
  5.Berk M, du Plessis AD, Birkett M et al (1997) An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly duloxetine depression study group. Int Clin Psychopharmacol 12(3):137鈥?40CrossRef PubMed
  6.Willis WD, Westlund KN (1997) Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14(1):2鈥?1CrossRef PubMed
  7.Goldstein DJ, Lu Y, Detke MJ et al (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109鈥?18CrossRef PubMed
  8.Smith EM, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359鈥?367PubMed Central CrossRef PubMed
  9.Common Terminology Criteria for Adverse Events version 4. http://鈥媍tep.鈥媍ancer.鈥媑ov/鈥媝rotocolDevelopm鈥媏nt/鈥媏lectronic_鈥媋pplications/鈥媍tc.鈥媓tm
  10.Nagashima M, Ooshiro M, Moriyama A et al (2014) Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients. Support Care Cancer. doi:10.鈥?007/鈥媠00520-014-2132-4 PubMed Central PubMed
  11.Takenaka M, Iida H, Matsumoto S, Yamaguchi S et al (2013) Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel. Am J Hosp Palliat Care 30(7):734鈥?36CrossRef PubMed
  12.Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941鈥?967CrossRef PubMed
  13.Baldwin RM, Owzar K, Zembutsu H et al (2012) A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 15:18
  14.Hertz DL, Roy S, Motsinger-Reif AA et al (2013) CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. Ann Oncol 24(6):1472鈥?478PubMed Central CrossRef PubMed
  15.Albers JW, Chaudhry V, Cavaletti G et al (2011) Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev 2:CD005鈥揅D228
  16.Hammack JE, Michalak JC, Loprinzi CL et al (2002) Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98:195鈥?03CrossRef PubMed
  17.Rao RD, Flynn PJ, Sloan JA et al (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112:2802鈥?808CrossRef PubMed
  18.Kautio AL, Haanp盲盲 M, Saarto T et al (2008) Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manag 35:31鈥?9CrossRef
  19.Barton DL, Wos EJ, Qin R et al (2011) A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 19:833鈥?41PubMed Central CrossRef PubMed
  
• 作者单位：Yasuo Hirayama (1)
  Kunihiko Ishitani (2)
  Yasushi Sato (3)
  Satoshi Iyama (3)
  Kohichi Takada (3)
  Kazuyuki Murase (3)
  Hiroyuki Kuroda (7)
  Yasuhiro Nagamachi (5)
  Yuichi Konuma (8)
  Akihito Fujimi (6)
  Tamotsu Sagawa (4)
  Kaoru Ono (3)
  Hiroto Horiguchi (3)
  Takeshi Terui (1)
  Kazuhiko Koike (2)
  Toshiro Kusakabe (1)
  Tsutomu Sato (3)
  Rishu Takimoto (3)
  Masayoshi Kobune (3)
  Junji Kato (3)
  
  1. Department of Hematology Oncology, Higashi Sapporo Hospital, Higashi Sapporo, Shiroishi-ku, Sapporo, 003-8585, Japan
  2. Division of Palliative Care, Higashi Sapporo Hospital, Sapporo, Japan
  3. Department of Medical Oncology/Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
  7. Department of Hematology Oncology, Seitetsu Memorial Hospital, Muroran, Japan
  5. Department of Hematology Oncology, Kiyota Hospital, Sapporo, Japan
  8. Department of Hematology Oncology, Asahikawa Red Cross Hospital, Asahikawa, Japan
  6. Department of Hematology Oncology, Oji Genaral Hospital, Tomakomai, Japan
  4. Department of Gastroenterology, Hokkaido Cancer Center, Sapporo, Japan
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Surgical Oncology
  Radiotherapy
  Diagnostic Radiology
  Internal Medicine
  Pathology
  
• 出版者：Springer Japan
• ISSN：1437-7772

文摘

Background Chemotherapy-induced peripheral neuropathy (CIPN) is difficult to manage. A phase III trial conducted in the United States demonstrated that duloxetine was effective for CIPN caused by taxane and platinum-based chemotherapy. No randomized trial of duloxetine for CIPN has been conducted in Japan.